Thoracic SMARCA4-deficient undifferentiated tumor
- PMID: 40212802
- PMCID: PMC11985039
- DOI: 10.1016/j.radcr.2025.02.109
Thoracic SMARCA4-deficient undifferentiated tumor
Abstract
Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is characterized by an undifferentiated rhabdoid morphology and SMARCA4 deficiency pathologically. In the 2021 revision of the WHO classification, it was categorized as an epithelial tumor because of its shared genetic background with smoking-related lung cancer. We describe the case of a 44-year-old man with a rapidly enlarging mediastinal mass observed on chest radiography and CT. The tumor was resistant to radiation therapy, chemotherapy, and immune checkpoint inhibitors, and the patient's survival time was approximately 5 months. Familiarity with the clinical background and imaging findings of thoracic SMARCA4-UT is crucial for early diagnosis and treatment planning.
Keywords: CT; Heavy smokers; Mediastinal mass; SMARCA4-deficient undifferentiated tumor.
© 2025 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures
References
-
- Zhang S., Xu W., Wu S., Chen M., Huang J., Sun Q., et al. Two cases of thoracic SMARCA4-deficient undifferentiated tumor: a case report. Clin Oncol 2022;7:1-4. Article 1964.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
